spacer
home > ict > autumn 2017 > important choices
PUBLICATIONS
International Clinical Trials

Important Choices

Although underrated, site selection is one of the most
significant processes for a successful trial. A recent report
suggests that 50% of sites under-enrol and 11% fail to register
a single patient in a given trial (1). Therefore, the process of
choosing locations is one of the most critical tasks in clinical
development, as picking the right one can significantly affect
study outcomes, time savings and overall expenditure.

Making the choice once the study or protocol design is clear is
best practice, as this ensures that comprehensive information
about the patient population, investigator specialities, personnel
and necessary equipment is available. This enables a strong
understanding on the types of challenges encounterable
through the site selection process, and having this information
upfront can help CROs and sponsors put the right strategies
in place (2).

The fundaments for a good selection plan are a combination
of picking high-quality and high-performing locations globally,
identifying efficiencies and strengths and optimising the use
of clinical technologies that produce real time access to data.
One of the first steps is to define the requirements, resources
and qualifications necessary for a given trial

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bandana Seesurn is Lead Project Manager at CIDP. She works with cross-functional teams to identify client needs and develop solutions for projects, leveraging expertise and operational capabilities. In her role, Bandana manages the full scope of trial set-up and conduct, from protocol, site selection and budgeting to regulatory submissions, project development, data management and reporting. She has acquired expertise in feasibility studies, site qualification and management, human and financial resource management and regulatory affairs. She has a bachelor’s degree in biomedical science and a master’s degree in pharmaceutical science with management studies from Kingston University London, UK.
spacer
Bandana Seesurn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and clinical chemistry enzymes, for the in-vitro diagnostics market. Now with the acquisition of MBS they have strengthened their antibody offering, providing a comprehensive portfolio and custom services to deliver a total reagent solution for any immunoassay development.
More info >>

White Papers

Case Study: Emerade® Auto-Injector

SHL Group

The Emerade® Auto Injector is an intuitive disposable 2-step auto injector designed to deliver adrenaline via intramuscular injection during emergency use. The exterior of the device has a simple and sleek industrial design with the aim to minimize confusion for users. To achieve the penetration force required for an intramuscular injection while still ensuring the dosage is delivered correctly and needle protection mechanisms are in place, the Emerade Auto Injector is equipped with an advanced 3 spring technology. The device is also available in 3 doses (150mcg, 300mcg, 500mcg), with each recommended for patients of different bodyweights to maximize efficacy.
More info >>

 
Industry Events

14th World Advanced Therapies & Regenerative Medicine Congress 2018

16-18 May 2018, Business Design Centre, London, United Kingdom

In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products).
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement